Jim McVeigh (@m075841)
Activity by Jim McVeigh
PHOENIX — A new Mayo Clinic study suggests that the care and support family members give to elderly widows following the death of their spouse may be a factor in delaying dementia.
The study presented at the Alzheimer’s Association International Conference in Copenhagen, Denmark last week was designed to evaluate the effects of widowhood in people with mild cognitive impairment - a precursor of dementia. The thinking had been that widowhood would accelerate the development of dementia in people with MCI but the study showed the opposite.
Mayo Clinic researchers used data on more than 3,500 people from the National Alzheimer’s Coordinating Center database, which compiles information collected at various Alzheimer’s disease Centers in the U.S. The researchers found that of the 1,078 subjects who developed dementia, people who remained married developed dementia at a younger age than those who were widowed (83 years old versus 92 years). [...]
Mayo Clinic also earned the No. 1 overall spot on the “Best Hospitals” list
PHOENIX — Mayo Clinic Hospital in Phoenix is ranked No. 1 in Arizona and the Phoenix metro area in the 25th U.S. News & World Report annual America’s Best Hospital List released today.
Hospitals included in the U.S. News Report such as the Mayo Clinic, are part of an elite group recognized for “breadth of excellence,” according to the magazine. Mayo Clinic in Arizona ranked nationally in 10 specialties including cancer, cardiology and heart surgery, ear, nose & throat, gastroenterology & GI surgery, geriatrics, gynecology, nephrology, neurology and neurosurgery, orthopedics and urology. In addition, Mayo Clinic in Arizona is recognized as high performing in diabetes and endocrinology.
Eye movement test detects concussions and possible 'silent' concussions
PHOENIX — A rapid, easy-to-administer eye movement test is showing great promise as a sideline concussion test for youth sports, a Mayo Clinic study finds.
In the study, Mayo Clinic researchers assessed high school hockey players using the King-Devick test. The test requires an athlete to read single-digit numbers displayed on cards. After suspected head trauma, the athlete is given the test, which takes about two minutes, and the results are compared to a baseline test administered previously. If the time needed to complete the test takes longer than the baseline test time, the athlete should be removed from play until evaluated by a medical professional.
About 150 high school hockey players received preseason testing to establish a baseline time in the study. During the subsequent season, 20 athletes had a suspected concussion. All 20 had a prolonged King-Devick test, and all were later clinically diagnosed with a concussion.
“Youth athletes are at a higher risk for concussion and a longer recovery time than adults,” says Amaal Starling, M.D., Mayo Clinic neurologist and a co-author of the study. “While the test has already been clinically validated for detecting concussion in collegiate and professional athletes, we wanted to ensure it was also validated in adolescents.” [...]
SCOTTSDALE, Ariz. — Apathy and agitation among otherwise healthy senior citizens may be an early sign of a condition leading to dementia, according to a study from Mayo Clinic published this month in the American Journal of Psychiatry.
Mayo researchers conducted a five-year prospective study to estimate the effect of initial neuropsychiatric symptoms to develop mild cognitive impairment. MCI is the intermediate stage between normal aging and dementia. People with MCI can develop dementia at a rate of 10 to 15 percent per year compared with 1 to 2 percent in the general population.
Researchers looked at data from the Mayo Clinic Study on Aging conducted in the early 2000s to compare behavioral symptoms to physiology from more than 10,000 people age 70 and above. Researchers studied psychiatric symptoms — agitation, apathy, anxiety, irritability and depression — at the baseline of the study and then again after five years to see if there were signs of MCI. It was determined that these baseline psychiatric symptoms are better predictors of increasing the risk of incident mild cognitive impairment than even physiological biomarkers, says study author Yonas Geda, M.D., a professor of Neurology and Psychiatry at Mayo Clinic in Arizona.
Journalists: Soundbites of Dr. Geda discussing the research are available in the downloads.
PHOENIX — March 19, 2014 — A Mayo Clinic study reviewed data on more than 290,000 men with prostate cancer from the past 20 years and found that African-American men are at increased risk for poorer survival rate following prostate cancer treatment compared to other minority groups. The study was recently published in Mayo Clinic Proceedings.
Researchers say that it has long been known that the survival rates of African-American men are less than Caucasian men but there was less information about other minorities such as Hispanics and Asians. Using data from the National Cancer Institute, the researchers used consistent clinical parameters among the groups and found that the survival rates for Hispanics and Asians were about the same as Caucasian.
“Theoretically, if all clinical and demographic variables are the same and people have similar access to treatment, they should have the equal survival rates,” says Mark D. Tyson, II, M.D, a urologist at Mayo Clinic in Arizona. “We found that is not the case.”
Dr. Tyson said the research team believes that the disparity can be attributed to post treatment factors. He said the next phase of the research will examine what post treatment factors contribute to the survival rate. He said that it is important for both physicians and patients to know that the disparity exists and there could be a variety of reasons why.
“What we do know is that with all other things being equal there is still this disparity… and the study really points to that post treatment period,” Dr. Tyson says. “The message that patients and clinicians can take away from this study is that patients need to be followed closely particularly if they are of African-American descent.”
About Mayo Clinic
Recognizing 150 years of serving humanity in 2014, Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit 150years.mayoclinic.org, http://www.mayoclinic.org and newsnetwork.mayoclinic.org.
STEAMBOAT SPRINGS, Colo. — Mayo Clinic and Yampa Valley Medical Center officials announced today that the Steamboat Springs hospital is the newest member of the Mayo Clinic Care Network. The network connects Mayo Clinic and health care providers who are interested in working together to enhance the delivery of locally provided high quality health care. Yampa Valley Medical Center is the second hospital in Colorado to be invited to join the network.
"We are pleased to announce this collaboration with Mayo Clinic,” said Frank May, CEO, Yampa Valley Medical Center. “We share a common philosophy and commitment to improve the delivery of health care and now our relationship through the Mayo Clinic Care Network will allow our physicians and providers to have access to Mayo’s knowledge and expertise to best address the needs of our patients in northwest Colorado.” [...]
PHOENIX – Mayo Clinic will host a special sneak preview of the highly anticipated documentary, Head Games: The Global Concussion Crisis.
WHEN - Saturday, March 8 at 6:30 p.m.
WHERE - the Phoenix campus of Mayo Clinic, 5777 East Mayo Boulevard.
BACKGROUND – From the acclaimed director Steve James (Academy Award-nominated Hoop Dreams, Emmy Award-winning The Interrupters), Head Games: The Global Concussion Crisis is a revealing documentary featuring never-before-seen neurological findings related to rugby and soccer players that will serve as a wake-up call for people who think that the devastating chronic effects of repetitive head trauma are only an American football and boxing injury. [...]
SCOTTSDALE, Ariz. — Feb. 26, 2014 — The future holds promise for multiple sclerosis research based on advancements of the past two decades according to a review from Mayo Clinic neurologists published in Mayo Clinic Proceedings.
The paper states that many people with newly diagnosed or early stage MS are overwhelmed by the combination of uncertain prognosis and the often-unsettling prospect of starting preventive measures that are used indefinitely. However, the authors say that patients and physicians can benefit from an awareness of recent and emerging developments.
“MS is the second most common disabling disease of young adults - it is a lifelong disease with an unpredictable clinical course for the most part,” said Dean Wingerchuk, M.D., Mayo Clinic neurologist and co-author of the review. “That means that people are challenged with making decisions about treatment. It’s important for both the patient and physicians to be aware of current and emerging therapies to make appropriate decisions going forward.”
Journalists: Sound bites with Dr. Wingerchuk are available in the downloads.
Dr. Wingerchuk said that MS research has been prolific and that scientific advances in understanding the relapsing form of the disease have led to the recent development of several new treatments. [...]